229 related articles for article (PubMed ID: 20139375)
1. Dysregulation of the Wnt/beta-catenin signaling pathway in canine cutaneous melanotic tumor.
Han JI; Kim DY; Na KJ
Vet Pathol; 2010 Mar; 47(2):285-91. PubMed ID: 20139375
[TBL] [Abstract][Full Text] [Related]
2. Alteration in E-cadherin/β-catenin expression in canine melanotic tumors.
Han JI; Kim Y; Kim DY; Na KJ
Vet Pathol; 2013 Mar; 50(2):274-80. PubMed ID: 22895538
[TBL] [Abstract][Full Text] [Related]
3. Loss of membranous expression of beta-catenin is associated with tumor progression in cutaneous melanoma and rarely caused by exon 3 mutations.
Demunter A; Libbrecht L; Degreef H; De Wolf-Peeters C; van den Oord JJ
Mod Pathol; 2002 Apr; 15(4):454-61. PubMed ID: 11950921
[TBL] [Abstract][Full Text] [Related]
4. Target genes of the WNT/beta-catenin pathway in Wilms tumors.
Zirn B; Samans B; Wittmann S; Pietsch T; Leuschner I; Graf N; Gessler M
Genes Chromosomes Cancer; 2006 Jun; 45(6):565-74. PubMed ID: 16575872
[TBL] [Abstract][Full Text] [Related]
5. Activation of Wnt/beta-catenin/Tcf signaling pathway in human astrocytomas.
Sareddy GR; Panigrahi M; Challa S; Mahadevan A; Babu PP
Neurochem Int; 2009 Sep; 55(5):307-17. PubMed ID: 19576519
[TBL] [Abstract][Full Text] [Related]
6. [Nuclear beta-catenin localization is not sufficient for canonical Wnt signaling activation in human meianoma cell lines].
Kulikova KV; Posviatenko AV; Gnuchev NV; Georgiev GP; Kibardin AV; Larin SS
Mol Biol (Mosk); 2011; 45(5):884-91. PubMed ID: 22393786
[TBL] [Abstract][Full Text] [Related]
7. Redundant expression of canonical Wnt ligands in human breast cancer cell lines.
Benhaj K; Akcali KC; Ozturk M
Oncol Rep; 2006 Mar; 15(3):701-7. PubMed ID: 16465433
[TBL] [Abstract][Full Text] [Related]
8. Activation of Wnt/beta-catenin signaling in distinct histologic subtypes of human germ cell tumors.
Fritsch MK; Schneider DT; Schuster AE; Murdoch FE; Perlman EJ
Pediatr Dev Pathol; 2006; 9(2):115-31. PubMed ID: 16822086
[TBL] [Abstract][Full Text] [Related]
9. Aberrant nuclear localization of beta-catenin without genetic alterations in beta-catenin or Axin genes in esophageal cancer.
Kudo J; Nishiwaki T; Haruki N; Ishiguro H; Shibata Y; Terashita Y; Sugiura H; Shinoda N; Kimura M; Kuwabara Y; Fujii Y
World J Surg Oncol; 2007 Feb; 5():21. PubMed ID: 17309796
[TBL] [Abstract][Full Text] [Related]
10. [The role of beta-catenin in rat embryonic development and tumorigenesis].
Wang QM; Yang KM; Zhou HY; Li X; Yang HJ; Li YS
Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Nov; 37(6):872-5. PubMed ID: 17236583
[TBL] [Abstract][Full Text] [Related]
11. Dysregulation of Wnt pathway components in human salivary gland tumors.
Queimado L; Obeso D; Hatfield MD; Yang Y; Thompson DM; Reis AM
Arch Otolaryngol Head Neck Surg; 2008 Jan; 134(1):94-101. PubMed ID: 18209144
[TBL] [Abstract][Full Text] [Related]
12. [Study on the role of Wnt/beta-catenin signaling transduction pathway in hepatocellular carcinoma cell line HepG2 and L02 cell line].
Wang QM; Jia LQ; Zhou HY; Li YS
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Oct; 23(10):926-8. PubMed ID: 17908501
[TBL] [Abstract][Full Text] [Related]
13. [Role of Wnt/beta-catenin signaling transduction pathway in rat hepatocarcinogenesis].
Wang QM; Li X; Jia LQ; Yang KM; Zhou HY; Yang HJ
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 Jul; 22(4):454-7. PubMed ID: 16806007
[TBL] [Abstract][Full Text] [Related]
14. beta-Catenin mutation and its nuclear localization are confirmed to be frequent causes of Wnt signaling pathway activation in pilomatricomas.
Xia J; Urabe K; Moroi Y; Koga T; Duan H; Li Y; Furue M
J Dermatol Sci; 2006 Jan; 41(1):67-75. PubMed ID: 16378715
[TBL] [Abstract][Full Text] [Related]
15. The Wnt-signaling pathway is not implicated in tumorigenesis of Merkel cell carcinoma.
Liu S; Daa T; Kashima K; Kondoh Y; Yokoyama S
J Cutan Pathol; 2007 Jan; 34(1):22-6. PubMed ID: 17214850
[TBL] [Abstract][Full Text] [Related]
16. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway.
Shan BE; Wang MX; Li RQ
Cancer Invest; 2009 Jul; 27(6):604-12. PubMed ID: 19440933
[TBL] [Abstract][Full Text] [Related]
17. Sox17, the canonical Wnt antagonist, is epigenetically inactivated by promoter methylation in human breast cancer.
Fu DY; Wang ZM; Li-Chen ; Wang BL; Shen ZZ; Huang W; Shao ZM
Breast Cancer Res Treat; 2010 Feb; 119(3):601-12. PubMed ID: 19301122
[TBL] [Abstract][Full Text] [Related]
18. The Wnt receptor FZD1 mediates chemoresistance in neuroblastoma through activation of the Wnt/beta-catenin pathway.
Flahaut M; Meier R; Coulon A; Nardou KA; Niggli FK; Martinet D; Beckmann JS; Joseph JM; Mühlethaler-Mottet A; Gross N
Oncogene; 2009 Jun; 28(23):2245-56. PubMed ID: 19421142
[TBL] [Abstract][Full Text] [Related]
19. Phospholipase D1 drives a positive feedback loop to reinforce the Wnt/beta-catenin/TCF signaling axis.
Kang DW; Lee SH; Yoon JW; Park WS; Choi KY; Min do S
Cancer Res; 2010 May; 70(10):4233-42. PubMed ID: 20442281
[TBL] [Abstract][Full Text] [Related]
20. Myogenesis in Wilms' tumors is associated with mutations of the WT1 gene and activation of Bcl-2 and the Wnt signaling pathway.
Fukuzawa R; Heathcott RW; Sano M; Morison IM; Yun K; Reeve AE
Pediatr Dev Pathol; 2004; 7(2):125-37. PubMed ID: 14994125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
